RECOMBINATE

This brand name is authorized in Estonia, Lithuania, Poland, South Africa

Active ingredients

The drug RECOMBINATE contains one active pharmaceutical ingredient (API):

1 Factor VIII (antihemophilic factor)
UNII P89DR4NY54 - ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT

Octocog alfa (Full length recombinant human coagulation factor VIII (rDNA)) is a purified protein that has 2,332 amino acids. It is produced by recombinant DNA technology in baby hamster kidney cells (BHK) into which the human factor VIII gene has been introduced.

Read about Octocog alfa

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B02BD02 Coagulation factor VIII B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1007648, 1007671, 1007705, 1484883, 1484939, 1484940
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1067501, 1067502, 1067503, 1070020, 1070021, 1070022
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100150305, 100182370, 100182386, 100182400, 100298278, 100298284
Country: ZA Health Products Regulatory Authority Identifier(s): A39/30.3/0591, A39/30.3/0592, A39/30.3/0593

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.